Related Experiment Video
Updated: Nov 19, 2025

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
The role of miR-29 family in disease
Masahiro Horita1, Colin Farquharson1, Louise A Stephen1
1The Roslin Institute and Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Midlothian, Scotland, UK.
Abstract:
MicroRNAs are small noncoding RNAs that can bind to the target sites in the 3'-untranslated region of messenger RNA to regulate posttranscriptional gene expression. Increasing evidence has identified the miR-29 family, consisting of miR-29a, miR-29b-1, miR-29b-2, and miR-29c, as key regulators of a number of biological processes. Moreover, their abnormal expression contributes to the etiology of numerous diseases. In the current review, we aimed to summarize the differential expression patterns and functional roles of the miR-29 family in the etiology of diseases including osteoarthritis, osteoporosis, cardiorenal, and immune disease. Furthermore, we highlight the therapeutic potential of targeting members of miR-29 family in these diseases. We present miR-29s as promoters of osteoblast differentiation and apoptosis but suppressors of chondrogenic and osteoclast differentiation, fibrosis, and T cell differentiation, with clear avenues for therapeutic manipulation. Further research will be crucial to identify the precise mechanism of miR-29 family in these diseases and their full potential in therapeutics.
Insights
The miR-29 family of microRNAs plays a key role in various diseases. Targeting these microRNAs shows therapeutic potential for conditions like osteoarthritis and immune disorders.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- MicroRNAs (miRNAs) are small noncoding RNAs regulating gene expression posttranscriptionally.
- The miR-29 family (miR-29a, miR-29b, miR-29c) is implicated in diverse biological processes.
- Dysregulation of miR-29 family members is linked to various pathological conditions.
Purpose of the Study:
- To review the differential expression and functions of the miR-29 family in disease.
- To explore the therapeutic potential of targeting miR-29 family members in specific diseases.
- To summarize the roles of miR-29s in osteoarthritis, osteoporosis, cardiorenal, and immune diseases.
Main Methods:
- Literature review of studies on miR-29 family expression and function.
- Analysis of miR-29 family's role in disease pathogenesis.
- Evaluation of therapeutic strategies targeting miR-29s.
Main Results:
- miR-29s promote osteoblast differentiation and apoptosis.
- miR-29s suppress chondrogenic and osteoclast differentiation, fibrosis, and T cell differentiation.
- Abnormal miR-29 expression is associated with osteoarthritis, osteoporosis, cardiorenal, and immune diseases.
Conclusions:
- The miR-29 family exhibits complex regulatory roles in various diseases.
- Targeting the miR-29 family presents promising therapeutic avenues for multiple conditions.
- Further research is needed to elucidate precise mechanisms and therapeutic applications.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Experimental RNAi
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

